An expert panel of Indiaâs drugs regulator may next week consider approving Covovax, the second Covid-19 vaccine developed by the Serum Institute of India, to be used as a booster dose, according to people familiar with the matter.
An expert panel of Indiaâs drugs regulator may next week consider approving Covovax, the second Covid-19 vaccine developed by the Serum Institute of India, to be used as a booster dose, according to people familiar with the matter.